PeptideAmerica

Legal

How this reference is funded

Peptide America is reader-supported through affiliate commissions; when a reader begins care through certain supplier links, this site is paid a commission by that supplier, at no additional cost to the reader.

The separation that matters here

A molecule's regulatory posture is a matter of public record, drawn from FDA labeling, the 503A bulk drug substances list and named regulatory filings, and it is not influenced by whether any supplier pays to appear beside it; a compound that cannot lawfully be compounded is recorded as such regardless of commercial interest.

Suppliers holding a commercial relationship with this site are listed ahead of those that do not, which is the one place the funding is visible in the output.

Where no commercial link appears at all

Some molecules carry no supplier list. Where a compound is research-use-only, withdrawn, or otherwise not lawfully obtainable through a US prescriber, the monograph presents the evidence and stops; no commercial destination is offered, because there is no lawful one to offer.

What this publication is

Peptide America is an independent reference publication. It is not a pharmacy, a compounder, a prescriber or a telehealth service, and it holds no relationship with any manufacturer beyond standard affiliate agreements.

Nothing published here constitutes medical advice, and a monograph is not a recommendation to use a compound; readers considering any therapy should consult a licensed clinician.

Contact

Analytics and the opt-out are described in the privacy notes. Corrections, sourcing questions and requests for the record behind a status: editor@peptideamerica.org.